MINNEAPOLIS (WCCO) — Hennepin Healthcare has launched two clinical trials for a drug to see if it will help COVID-19 patients.

The trials are being doing through the Hennepin Healthcare Research Institute.

READ MORE: COVID In Minnesota: Vulnerable Residents Crossing State Lines For Vaccine

Researchers are studying the safety and efficacy of the drug remdesivir to treat hospitalized patients with moderate or severe cases of COVID-19. It’s an antiviral drug previously tested in Ebola patients.

READ MORE: How Do You Get Picked For Jury Duty?

Around 1,000 patients around the world will be in the trial. About 70 of them could be through Hennepin Healthcare.

MORE NEWS: 'The Worst Night Of My Life:' Man Mourns Grandmother Killed In Home Explosion; Mom Recovering From Burns

“The clinical trials will help to determine if remdesivir is a safe and effective drug that can improve outcomes for patients diagnosed with COVID-19 here at Hennepin Healthcare and in the broader community,” principal investigator Dr. Jason Baker said.